Company page

Soleno Therapeutics, Inc.

Soleno Therapeutics, Inc. is a public company traded under the ticker SLNO in the American market. The company has a market capitalization of approximately $2.76 billion. Soleno focuses on developing innovative therapies for rare diseases, aiming to improve the lives of patients with unmet medical needs.